Meta-analysis of Short-term Outcomes of Randomized Controlled Trials of LigaSure vs Conventional Hemorrhoidectomy

Evaluation and management of hemorrhoids: Italian society of colorectal surgery (SICCR) consensus statement

“…Pain following hemorrhoidectomy is a common occurrence, and studies have evaluated the use of LigaSure in hemorrhoidectomy [69][70][71][72][73][74]. In a Cochrane Review comparing conventional hemorrhoidectomy to LigaSure, there was a trend for less pain and a lower incidence of complications associated with LigaSure, but most results were not significantly different [71].…”

Minimizing intraoperative bleeding using a vessel-sealing system and splenic hilum hanging maneuver in laparoscopic splenectomy

“…One patient required a second-look laparoscopy for hemoperitoneum, and another required additional clipping for arterial bleeding. Moreover, blood loss Postoperative hospital stay, days (range) 6.5 (3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14) HALS hand-assisted laparoscopic splenectomy could not be determined (considered 0 ml for this study) in 15 patients (52%). Conversion from HALS to open splenectomy was necessary in one patient (3.3%) due to uncontrollable bleeding from a huge varicose vein in the splenic hilum.…”

LigaSure versus Milligan–Morgan hemorrhoidectomy: a prospective randomized clinical trial

“…This, in addition to reduced operative time, may compensate for the higher cost of the LigaSure electrodes, particularly since reduced pain did not lead to a shorter hospital stay. Tan et al [20], in their meta-analysis study, reported that the cost of each single-use Ligasure device is about $156 and that by making possible shortened operative times, decreased blood loss, and reduced postoperative pain, LigaSure may produce a cost benefit, though this assessment was not performed in any of the studies analyzed. A further study is obviously and admittedly needed to verify cost-effectiveness of LH versus OH.…”